Business
Citi slaps buy rating on ResMed shares
Image source: Getty Images
ResMed Inc (ASX: RMD) shares are in the red so far in 2025.
After slipping from 52-week highs of $40.50 in January, shares in the respiratory device company currently fetch $35.71 apiece.
This brings the stock back to its September 2024 levels.
With shares at these…
Continue Reading
-
Noosa News23 hours agoGippsland vegetable farm accused of underpaying migrant workers
-
General24 hours agoFour escape injury after jumping from three-storey unit on fire in Newcastle
-
General16 hours agoMan refused bail charged with depicting Adolf Hitler and Nazi symbols on boat
-
Noosa News13 hours agoAlternative pathways to university explained